Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica (NMO IgG+) and genetic susceptibility, potential ethnic influences.
Reciprocal communication between the nervous and immune systems: crosstalk, back-talk and motivational speeches.
Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy.
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors.
Interferon-β Modulates Inflammatory Response in Cerebral Ischemia.
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
A systematic review of stress-management interventions for multiple sclerosis patients.
Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG.
Let's rehabilitate cognitive rehabilitation in multiple sclerosis.
Pharmacological treatment for memory disorder in multiple sclerosis.
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses.
Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis.
Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs.
Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort.
Epidemiology and genetic aspects of multiple sclerosis in India.
Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.
Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
Autoimmune disease: SIRT1 inhibition suppresses multiple sclerosis.
Pages
« first
‹ previous
…
698
699
700
701
702
703
704
705
706
…
next ›
last »